HIGHLIGHTS
- who: Bridget N. J. Watson from the University of have published the research: Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
- what: The authors examine the outcome of CRISPR-Cas immunity using Pectobacterium atrosepticum, which carries a type I-F system, and two unrelated virulent phages as model systems. Instead, the authors propose that CRISPR-Cas immunity still enables a window of time for the virulent phage to express toxic products or takeover host resources and machinery18. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.